max dose exceeds $340
Currently, the litigation includes over 1,300 lawsuits against Novo Nordisk and Eli Lilly, with numbers expected to grow as more individuals report complications like stomach paralysis and intestinal blockages
A 42-year-old female with longstanding profound fatigue, chronic pain, asthma, multiple food intolerances, GI symptoms including diarrhea, urticaria, food cravings, weight gain, and migraine who was essentially housebound due to constant exhaustion (she estimated 30% of normal energy) took tirzepitide at 3.75 mg principally to address obesity
Once reconstituted, keep refrigerated at 2-8C
MOTS-c represents a frontier in metabolic peptide research rather than a proven alternative to tirzepatide